Is limited pulmonary resection equivalent to lobectomy for surgical management of stage i non-small-cell lung cancer?

Interactive Cardiovascular and Thoracic Surgery

Volumn 14, Issue 6, 2012, Pages 816-820

  De Zoysa, Maya K ^a   Hamed, Dima ^b   Routledge, Tom ^b   Scarci, Marco ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Limited resection; Lobectomy; Non small cell lung cancer; Segmentectomy; Wedge resection

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; EARLY CANCER; EVIDENCE BASED MEDICINE; FITNESS; FORCED EXPIRATORY VOLUME; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LENGTH OF STAY; LUNG ALVEOLUS CELL CARCINOMA; LUNG DIFFUSION CAPACITY; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MORBIDITY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RELIABILITY; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUMOR VOLUME; WEDGE RESECTION;

AGE FACTORS; AGED; BENCHMARKING; CARCINOMA, NON-SMALL-CELL LUNG; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LENGTH OF STAY; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84863473693     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs031     Document Type: Article

References (19)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-9.
2. Nakamura H, Kawasaki N, Taguchi M, Kabasawa K. Survival following lobectomy vs. limited resection for stage I lung cancer: a meta-analysis. Br J Cancer 2005;92:1033-7.
3. Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003;125:924-8.
4. Keenan RJ, Landreneau RJ, Maley RH, Singh D, Marcherey R, Bartley S et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 2004;78:228-33.
5. Read RC, Yoder G, Schaeffer RC. Survival after conservative resection for T1 N0 M0 non-small cell lung cancer. Ann Thorac Surg 1990;49:391-8.
6. Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 2001;71:956-60.
7. Okada M, Koike T, Higashiyama M, Yamata Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769-75.
8. Harpole D, Herndon J, Young W, Wolfe W, Sabiston D. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76:787-96.
9. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22.
10. Landreneau RJ, Sugarbaker DJ, Mack MJ, Hazelrigg SR, Luketich JD, Fetterman L et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997;113: 691-8.
11. El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC et al. Outcomes of sublobar resection versus lobectomy for stage I nonsmall cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006;82:408-16.
12. Mery CM, Pappas AN, Bueno R, Colson Y, Linden P, Sugarbaker D et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the Surveillance, Epidemiology, and End Results database. Chest 2005;128: 237-45.
13. Nakamura H, Taniguchi Y, Miwa K, Adachi Y, Fujioka S, Haruki T et al. Comparison of the surgical outcomes of thoracoscopic lobectomy, segmentectomy, and wedge resection for clinical stage I non-small cell lung cancer. Thorac Cardiovasc Surg 2011;59:137-41.
14. Okumura M, Goto M, Ideguchi K, Tamura M, Sasaki H, Tanaka H et al. Factors associated with outcome of segmentectomy for non-small cell lung cancer: long-term follow-up study at a single institution in Japan. Lung Cancer 2007;58:231-7.
15. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg 1994;107: 1087-93.
16. Kraev A, Rassias D, Vetto J, Torosoff M, Ravichandran P, Clement C et al. Wedge resection vs. lobectomy: 10-year survival in stage I primary lung cancer. Chest 2007;131:136-40.
17. Rami-Porta R, Tsuboi M. Sublobar resection for lung cancer. Eur Respir J 2009;33:426-35.
18. Sienel W, Dango S, Kirschbaum A, Cucuruz B, Hörth W, Stremmel C et al. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg 2008;33:728-34.
19. Baldwin DR, White B, Schmidt-Hansen M, Champion AR, Melder AM. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. BMJ 2011;342:d2110.